Pindolol
Check on isomerdesign
Pindolol
Check on pubchem
Pindolol
Check on drugmap
Pindolol
Check on wiki
Data
InChI: InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3
Synonyms: Pindolol (JP17/USP/INN),Lopac0_000955, LB-46,Calvisken,5-21-03-00017 (Beilstein Handbook Reference),Tox21_110221_1,Pindolol [USAN:USP:INN:BAN:JAN],PINDOLOL [VANDF],Glauco-visken, Pectobloc (TN),EN300-18518413,DSSTox_RID_77043,NCGC00015786-06, Blocklin-L, 1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol,NCGC00261640-01,Carvisken (TN),AB00052072_12,SR-01000000027-5,LB-46,KBio1_000837,KBio2_004157, (1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol,Prestwick3_000090,FT-0673907,Blockin L,4-(3-(Isopropylamino)-2-hydroxypropoxy)indole,NCGC00015786-10,NSC 757276,MLS002548891,AB00052072, Pindololum,Dl-lb-46,Durapindol,4-(2-Hydroxy-3-isopropylaminopropoxy)-indole,CAS-13523-86-9, DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole, Pynastin (TN),(+/-)-LB-46,1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol,PINDOLOL [ORANGE BOOK],HMS2089I21,NCGC00024925-04,2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-,N-(2-HYDROXY-3-(1H-INDOL-4-YLOXY)PROPYL)-N-ISOPROPYLAMINE,Spectrum3_000547,HMS3414J03, P 0778, (+-)-Pindolol, Cardilate (TN),PINDOLOL [MART.],Apo-pindol,(+-)-Pindolol,HMS502J19,PINDOLOL [MI],BRD-A97701745-001-09-5,Prestwick1_000090, 4-(3-(Isopropylamino)-2-hydroxypropoxy)indole, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol,NCGC00015786-08,SCHEMBL5219,PINDOLOL,(-),1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #,(-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol,1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol),NCGC00024925-06,1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol,SW196641-3,1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol,HMS1920H16,BRD-A97701745-001-05-3,CCRIS 9215,NCGC00015786-14,1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol,2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-,Pindololum,Q418101,PINDOLOL [USP MONOGRAPH],2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-, Calvisken, 4-(2-Hydroxy-3-isopropylaminopropoxy)-indole,Spectrum2_001285,(rs)-pindolol, Durapindol (TN), Carvisken (TN),Pectobloc,Pindololum [INN-Latin],Spectrum5_001266,pindolol,C07445,l-Pindolol,SB17015,Tox21_500955, 1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol,Pynastin,KBioGR_000958,1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol,1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol, Glauco-visken, Blockin L,BDBM50019443,Spectrum_001109,PINDOLOL [JAN],LP00955,C90604,DL-Pindolol,KBio2_006725, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol,HMS3262P12,Blocklin-L, Decreten,Tox21_110221,SPBio_001289,BJ4HF6IU1D,CHEMBL500,SMR000059120,BPBio1_000022,(+/-)-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE, Pindolol [USAN:INN:BAN:JAN],Blocklin,Pindolol, United States Pharmacopeia (USP) Reference Standard, Durapindol,SR-01000000027-2,AB00052072_13, LB46,KBioSS_001589,PINDOLOL [USP-RS],Prinodolol, LB 46,Pindolol,1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol,BSPBio_002193,PINDOLOL [HSDB],Carvisken,PDSP2_000760, Decreten (TN),Prestwick2_000090,HMS1568A22,NCGC00024925-03,SR-01000000027,1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol,UNII-BJ4HF6IU1D, Calvisken (TN),13523-86-9,NCGC00015786-22,DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole,2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-,(+/-)-PINDOLOL, Visken (TN), Glauco-Viskin, DL-LB 46, Pindolol (JP15/USP/INN),PDSP1_000771, 1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,PDSP2_000759,CCG-39223,1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol,PINDOLOL [INN],HMS3742C07, Betapindol (TN),CHEBI:8214,NINDS_000837,PINDOLOL [EP MONOGRAPH],Blocklin-L (TN),PDSP1_000772,PINDOLOL COMPONENT OF VISKAZIDE,SBI-0050929.P004,1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol,EINECS 236-867-9, Blocklin L, Pynastin,BS-42390, Blocklin, Prinodolol,Blocklin L, Blocklin-L (TN), Carvisken,PINDOLOL [USAN],DL-LB 46,Glauco-Viskin,HMS3267K17,Betapindol,P 0778,NCGC00015786-07, P-6820, 1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol,HMS3885N04,DSSTox_GSID_23476,KBio3_001693,NCGC00015786-16,NCGC00015786-09,AB00052072-11,PINDOLOL [WHO-DD],P-6820,Visken,Pharmakon1600-01500488,4-(3-Isopropylamino-2-hydroxypropoxy)indole,1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol),HSDB 6539,AKOS015969756,IDI1_000837,523P869,LB 46,NCGC00024925-07,Spectrum4_000479,D00513,HMS3678H21,NCGC00015786-11, Pindololum [INN-Latin],1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol, Blockin L (TN),NC00467,NSC757276, Pectobloc,Oprea1_770884,NCGC00015786-13,4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE, 1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol,2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-, 1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol,Visken (TN),GTPL91,BSPBio_000020, DL-Pindolol,SPBio_001959,SPECTRUM1500488,(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol,NCGC00015786-20, Blocklin L (TN),EU-0100955,SR-01000000027-7, Prindolol (TN), 1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol,HMS2095A22,HMS3259I07,SDCCGSBI-0050929.P005,HMS2091P20, Pinbetol, 1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol,NSC-757276,SR-01000000027-4,NCGC00024925-05,CS-4473,DSSTox_CID_3476,DL-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE,L000006,DivK1c_000837,2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-,KBio2_001589, Pinbetol (TN),Prestwick_397,Pinbetol,Prestwick0_000090,(.+/-.)-Pindolol,Pindolol, >=98% (TLC), powder,Decreten,(+/-)-Pindolol-d7(iso-propyl-d7),HY-B0982,HMS3712A22, Visken,Pindolol, European Pharmacopoeia (EP) Reference Standard,DTXSID8023476,DB00960, Prindolol,BRN 1536506,EINECS 244-623-8,MLS000069496, Glauco-Visken (TN),1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,VISKAZIDE COMPONENT PINDOLOL,HMS3369E14
Estimated data
Solubility: -1.459 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 43.5% (prediction based on www.mdpi.com)
